AGBL2 and rheumatoid arthritis: We have in previous studies identified RA patient derived CCP2+ ACPA from a large number of generated human monoclonal antibodies (>250) from single B-cells from different tissues from seropositive RA patients (26, 27, 32, 41, 48, 49).